NCT02318446 Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics Status UNKNOWN Phase PHASE3
NCT02316847 An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray. Status TERMINATED Phase PHASE2
NCT02305771 Contributions From the Analysis of Graphs for Identification of Neural Cliques Status COMPLETED Phase NA
NCT02305329 Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation Status COMPLETED Phase PHASE1
NCT02288312 Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate Status COMPLETED Phase PHASE1
NCT02287415 The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin Status COMPLETED Phase PHASE1
NCT02286986 Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy Status COMPLETED Phase PHASE1
NCT02286271 Preliminary Testing of a Novel Device to Detect Epileptic Seizures Status COMPLETED Phase N/A
NCT02284880 Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate Status COMPLETED Phase PHASE1
NCT02284854 Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine Status COMPLETED Phase PHASE1
NCT02284828 Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function Status COMPLETED Phase PHASE1
NCT02283840 Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate Versus To-be-marketed Formulation Status COMPLETED Phase PHASE1
NCT02283827 Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin. Status COMPLETED Phase PHASE1
NCT02283814 A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate Status COMPLETED Phase PHASE1
NCT02283801 Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine. Status COMPLETED Phase PHASE1
NCT02283788 Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization Status COMPLETED Phase PHASE1
NCT02281591 Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine Status COMPLETED Phase PHASE1
NCT02281526 An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 Status COMPLETED Phase PHASE1
NCT02281448 Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive. Status COMPLETED Phase PHASE1